| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | GIGAMON INC | 77,812 | 2,766,000 | 2.70% | ||
| 52 | INTEGRATED DEVICE TECHNOLOGY | 119,277 | 2,823,000 | 2.76% | ||
| 53 | NXSTAGE MED INC COM | 117,779 | 3,160,000 | 3.09% | ||
| 54 | RTI SURGICAL HOLDINGS INC COM | 818,466 | 3,274,000 | 3.20% | ||
| 55 | OMNICELL INC | 88,617 | 3,602,000 | 3.52% | ||
| 56 | NEOGENOMICS INC | 494,882 | 3,905,000 | 3.82% | ||
| 57 | AKORN INCORPORATED | 190,793 | 4,594,000 | 4.49% | ||
| 58 | FINISAR CORP | 179,725 | 4,914,000 | 4.80% | ||
| 59 | TELIGENT INC NEW | 672,862 | 5,255,000 | 5.14% | ||
| 60 | Intersect ENT Inc | 353,251 | 6,058,000 | 5.92% | ||
| 61 | OCLARO INC | 868,636 | 8,530,000 | 8.34% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000892712-17-000422, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
